Tonghua Dongbao Pharmaceutical Co.,Ltd.’s Net Profit Rose 75.5% in First Half of 2022

Tonghua Dongbao Pharmaceutical Co.,Ltd. (通化东宝药业股份有限公司) (600867.SH) reported a net profit of 1.2 billion yuan in the first half of 2022, up 75.5% year-on-year.

Meanwhile, the company posted 1.4 billion yuan in revenue, down 16.5% year-on-year.

At the end of the reporting period, it had 6.9 billion yuan in total assets and 176.2 million yuan in total liabilities, with a liability-to-asset ratio of 2.6%.